Thrive Capital Management, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1845943
FORT WASHINGTON, PA
Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$4,361,635
+$121,025 QoQ
Shares Held
34,523
+13.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#614
of 2,266 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Thrive Capital Management, LLC holds $24,319,388 across 7 Drug Manufacturers - General names. GILD ranks #4 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,428 | $6,711,919 | |
| 2 | MRK |
Merck & Co., Inc.
|
42,844 | $5,505,454 | |
| 3 | LLY |
ELI LILLY & Co
|
4,356 | $5,224,717 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
34,523 | $4,361,635 | |
| 5 | AMGN |
Amgen Inc
|
4,477 | $1,621,211 | |
| 6 | ABBV |
AbbVie Inc.
|
1,905 | $479,374 | |
| 7 | AZN |
Astrazeneca PLC
|
2,189 | $415,078 |
All Filings in GILD
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,361,635 | 34,523 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $4,240,610 | 30,427 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $4,170,336 | 33,977 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,115,547 | 37,077 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $3,410,693 | 30,763 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,875,044 | 16,734 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,603,448 | 28,185 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,123,834 | 25,332 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,037,922 | 29,703 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,283,120 | 17,517 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $225,693 | 2,786 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $225,194 | 3,005 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $224,890 | 2,918 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $399,749 | 4,818 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $755,909 | 8,805 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $633,309 | 10,266 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $361,032 | 5,841 | Shares | Sole | 2022-08-08 | |
| No filing history on record for this holder in this stock. | ||||||